LUNGevity Foundation today announced a partnership with the Lung Cancer Research Foundation and Melanoma Research Alliance to co-fund new innovative research on PD-1 inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.
News & Views
Find out what’s new at the Lung Cancer Research Foundation. Included below are researcher spotlights, recent developments in lung cancer research — from LCRF grant recipients as well as others in the field, highlights from our signature fundraising events and more.
For media inquiries, please contact Director of Marketing & Communications Emily Krimbel at firstname.lastname@example.org.